MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617085802 A) filed by Minghui Pharmaceutical Hangzhou Limited; and Minghui Pharmaceutical Shanghai Limited on July 13, 2026, for Antigen-Binding Protein And Use Thereof.
Inventors include Liu, Bo; Zhu, Liyuan; Cao, Guoqing; Shi, Junwei; Cao, Yuting; and Weng, Xialian.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present invention relates to a nanobody or an antigen-binding fragment thereof that specifically binds to HER3, a composition containing the nanobody or the antigen-binding fragment thereof, and a nucleic acid molecule encoding the antibody or the antigen-binding fragment thereof. In addition, the present invention also relates to the use of the nanobody or the antigen-binding fragment thereof in the treatment and diagnosis of diseases.
Disclaimer: Curated by HT Syndication.
